Financial Year |
March 31 2023 |
Monetary Funds |
946,472,485.24 |
Held-for-trading Financial Assets |
143,428,142.95 |
Notes Receivable |
-- |
Accounts Receivable |
419,141,563.19 |
Advances to Suppliers |
40,407,398.17 |
Other Receivables |
85,144,957.31 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
11,588,545.91 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
1,168,929,566.41 |
Other Current Assets |
74,527,655.22 |
Total Current Assets |
2,889,640,314.40 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
74,663,375.54 |
Long-term Equity Investment |
14,897,224.69 |
Investment Properties |
117,867,715.75 |
Fixed Assetes |
571,402,334.08 |
Under-construction Projects |
19,259,382.21 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
167,924,680.67 |
R&D expenses |
-- |
Goodwill |
95,521.99 |
Long-Term Deferred and Prepaid Expenses |
109,687,688.72 |
Deferred Income Tax Assets |
67,748,114.60 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
2,584,829,785.13 |
Total Assets |
5,474,470,099.52 |
Short-Term Loans |
41,943,209.25 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
634,208,735.02 |
Accounts Received In Advance |
4,248,643.36 |
Employee Compensation Payable |
60,259,898.74 |
Taxes Payable |
13,858,219.80 |
Interest Payable |
-- |
Dividend Payable |
12,160,481.15 |
Other payables |
88,300,779.39 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
8,695,968.58 |
Other Current Liabilities |
15,158,127.22 |
Sub-Total of Current Liabilities |
982,985,240.69 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
31,931,394.15 |
Total Liabilities |
1,014,916,634.84 |
Paid-In Capital(Or Share Stock) |
795,695,940.00 |
Capital Surplus |
2,391,579,776.04 |
Surplus Reserve |
316,561,104.22 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
473,782,905.40 |
Minority Stockholder's Interest |
481,933,739.02 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,977,619,725.66 |
Owner's Equity(Stockholder's Equity) |
4,459,553,464.68 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
5,474,470,099.52 |